Welcome
Amgen Booth
Click on an area of the booth to explore.
About Amgen
Amgen is focused on addressing the needs of patients with mCRPC, a disease that significantly impacts QoL and has limited treatment options. Amgen is on the leading edge of immunotherapy development in prostate cancer, employing innovative trial design and advanced imaging technology with an aspiration to transform the lives of men with prostate cancer. Amgen is investigating various modalities designed to engage the patient’s own immune system to target tumor associated antigens and mediate killing of prostate cancer cells.